ESC/EASD Joint Guidelines on Diabetes and Cardiovascular Diseases

被引:0
|
作者
Motz, Wolfgang [1 ]
Doerr, Rolf [2 ]
机构
[1] Klin Grp Dr Guth GmbH & Co KG, Klinikum Karlsburg, D-17495 Karlsburg, Germany
[2] Akad Lehrpraxisklin TU, Praxisklin Herz & Gefasse Kardiol Angiol Radiol N, Dresden, Germany
关键词
Diabetes mellitus; Prediabetes; Cardiovascular diseases; Coronary heart disease; Coronary artery disease equivalent; Risk factors; Coronary revascularization; CORONARY-HEART-DISEASE; DRUG-ELUTING STENTS; ELEVATION MYOCARDIAL-INFARCTION; SUDDEN CARDIAC DEATH; BLOOD-PRESSURE; CLINICAL-OUTCOMES; GLUCOSE-TOLERANCE; RISK-FACTORS; FOLLOW-UP; MELLITUS;
D O I
10.1007/s00059-009-3203-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ESC/EASD (European Society of Cardiology/European Association for the Study of Diabetes) joint Guidelines on diabetes, pre-diabetes, and cardiovascular diseases have, for the first time, addressed diabetes mellitus and cardiovascular diseases (CVD) as a pathophysiological entity in Europe. Based on these guidelines, diabetes mellitus is regarded from the outset to be a cardiovascular disease, whose life-threatening complications myocardial infarction and stroke can only be avoided by an interdisciplinary concerted action. The most important information of these guidelines for the interdisciplinary cooperation of primary-care physicians, diabetologists and cardiologists are the postulations that patients with the main diagnosis diabetes mellitus with or without known CVD should, at regular intervals, be referred to a cardiologist, and patients with the main diagnosis CVD with or without diabetes mellitus should, at regular intervals, be referred to a diabetologist. Of fundamental importance is the prevention of diabetes and CVD by a comprehensive lifestyle modification including smoking cessation, regular physical activity and weight control, flanked by an evidence-based drug therapy. Within the framework of a multimodal risk management, an optimal antihypertensive therapy of a concomitant elevated blood pressure; a statin therapy in case of elevated LDL cholesterol or regardless of an elevated LDL in proven CVD; ACE inhibitors, angiotensin II receptor blockers, or beta-blockers in case of heart failure; and an anticoagulant therapy for the prevention of cardioembolic stroke in patients with atrial fibrillation all have class I recommendations. Concerning the preferred coronary revascularization procedure in diabetics, today no rigid general recommendation can be given in favor of or against coronary bypass surgery, or in favor of or against percutaneous coronary intervention. The decision for a specific revascularization procedure should, in any case, be based on a detailed analysis of the individual coronary anatomy.
引用
收藏
页码:21 / 29
页数:9
相关论文
共 50 条
  • [21] Comments on the 2019 ESC guidelines on diabetes, pre-diabetes and cardiovascular diseases
    Jimenez Navarro, Manuel
    Castro, Almudena
    Ballesteros Pradas, Sara
    Cruzado Alvarez, Concepcion
    Gomez Doblas, Juan Jose
    Marzal Martin, Domingo
    del Prado, Susana
    Valencia Serrano, Felix
    Breton, Irene
    Gomez Peralta, Fernando
    Mauricio, Didac
    Soto Gonzalez, Alfonso
    REVISTA ESPANOLA DE CARDIOLOGIA, 2020, 73 (05): : 354 - 360
  • [22] Diabetes, pre-diabetes and cardiovascular diseases in light of the 2019 ESC Guidelines
    Zandecki, Lukasz
    Janion-Sadowska, Agnieszka
    Kurzawski, Jacek
    Janion, Marianna
    MEDICAL STUDIES-STUDIA MEDYCZNE, 2020, 36 (02) : 148 - 155
  • [23] 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Summary of the document prepared by the Czech Society of Cardiology
    Taborsky, Milos
    Linhart, Ales
    Rosolova, Hana
    Spinar, Jindrich
    COR ET VASA, 2020, 62 (02) : 105 - 138
  • [24] Cardiologist comments on recommendations on diabetes mellitus, pre-diabetes and cardiovascular diseases ESC-EASD 2007
    Aleksandrov, An. A.
    DIABETES MELLITUS, 2008, 11 (01): : 93 - 96
  • [25] Comments on the guidelines (2023) of the ESC on the management of cardiovascular diseases in patients with diabetes
    Marx, Nikolaus
    Mueller-Wieland, Dirk
    Espinola-Klein, Christine
    Halle, Martin
    Birkenhagen, Annette
    Diemert, Patrick
    Mahfoud, Felix
    Wienbergen, Harm
    Schuett, Katharina
    KARDIOLOGIE, 2024, 18 (03): : 256 - 265
  • [26] ESC/EASD guideline sheds light on diabetes and cardiovascular disease management
    Chaplin, Steve
    PRACTICAL DIABETES, 2020, 37 (01) : 24 - 26
  • [28] Cardiovascular Risk Categories in Patients with Diabetes According to 2019 ESC/EASD Guidelines in Clinical Practice: Use of a Dedicated App (AWARE)
    Berra, Cesare C.
    Manfrini, Roberto
    Ghelardi, Renata
    Bollati, Paola M.
    Bucciarelli, Loredana
    Mirani, Marco
    Muratori, Milena
    Folli, Franco
    DIABETES, 2021, 70
  • [29] ESC Guidelines on the management of cardiovascular diseases during pregnancy
    Regitz-Zagrosek, Vera
    Lundqvist, Carina Blomstrom
    Borghi, Claudio
    Cifkova, Renata
    Ferreira, Rafael
    Foidart, Jean-Michel
    Gibbs, J. Simon R.
    Gohlke-Baerwolf, Christa
    Gorenek, Bulent
    Iung, Bernard
    Kirby, Mike
    Maas, Angela H. E. M.
    Morais, Joao
    Nihoyannopoulos, Petros
    Pieper, Petronella G.
    Presbitero, Patrizia
    Roos-Hesselink, Jolien W.
    Schaufelberger, Maria
    Seeland, Ute
    Torracca, Lucia
    Bax, Jeroen
    Auricchio, Angelo
    Baumgartner, Helmut
    Ceconi, Claudio
    Dean, Veronica
    Deaton, Christi
    Fagard, Robert
    Funck-Brentano, Christian
    Hasdai, David
    Hoes, Arno
    Knuuti, Juhani
    Kolh, Philippe
    McDonagh, Theresa
    Moulin, Cyril
    Poldermans, Don
    Popescu, Bogdan A.
    Reiner, Zeljko
    Sechtem, Udo
    Sirnes, Per Anton
    Torbicki, Adam
    Vahanian, Alec
    Windecker, Stephan
    Baumgartner, Helmut
    Deaton, Christi
    Aguiar, Carlos
    Al-Attar, Nawwar
    Garcia, Angeles Alonso
    Antoniou, Anna
    Coman, Ioan
    Elkayam, Uri
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2012, 40 : 70 - 120
  • [30] New ESC guidelines 2019 "Diabetes, prediabetes and cardiovascular diseases" Paradigm shift in reduction of cardiovascular risk in patients with diabetes mellitus
    Marx, N.
    HERZ, 2019, 44 (08) : 684 - 687